Amneal Pharmaceuticals, Inc.(AMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMRX Amneal Pharmaceuticals, Inc.

交易中 03-24 10:32:38 EDT

11.91

-0.01

-0.08%

最高11.95	最低11.71	成交量15.01万
今开11.77	昨收11.92	日振幅2.01%
总市值37.44亿	流通市值20.07亿	总股本3.14亿
成交额177.67万	换手率0.09%	流通股本1.69亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMRX","market":"US","secType":"STK","nameCN":"Amneal Pharmaceuticals, Inc.","latestPrice":11.91,"timestamp":1774362756516,"preClose":11.92,"halted":0,"volume":150073,"delay":0,"changeRate":-0.0008389261744966264,"floatShares":168501130,"shares":314362920,"eps":0.22,"marketStatus":"交易中","change":-0.01,"latestTime":"03-24 10:32:38 EDT","open":11.77,"high":11.95,"low":11.71,"amount":1776725.802621,"amplitude":0.020134,"askPrice":11.92,"askSize":108,"bidPrice":11.9,"bidSize":360,"shortable":3,"etf":0,"ttmEps":0.22,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1525665600000,"exchange":"NASDAQ","adjPreClose":11.92,"preHourTrading":{"tag":"盘前","latestPrice":11.85,"preClose":11.92,"latestTime":"09:20 EDT","volume":962,"amount":11410.150206,"timestamp":1774358420002,"change":-0.07,"changeRate":-0.005872,"amplitude":0.118289},"postHourTrading":{"tag":"盘后","latestPrice":11.9,"preClose":11.92,"latestTime":"18:11 EDT","volume":99490,"amount":1185892.83,"timestamp":1774303872326,"change":-0.02,"changeRate":-0.001678,"amplitude":0.005034},"volumeRatio":0.35292,"impliedVol":0.1665,"impliedVolPercentile":0.0677},"requestUrl":"/m/hq/s/AMRX/wiki","defaultTab":"wiki","newsList":[{"id":"1161811979","title":"财报前瞻 ｜Amneal Pharmaceuticals, Inc.本季度营收预计增14.18%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1161811979","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161811979?lang=zh_cn&edition=full","pubTime":"2026-02-20 10:10","pubTimestamp":1771553447,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals, Inc.将于2026年02月27日发布最新财报，市场关注营收与每股收益的增长韧性以及利润质量的修复迹象。市场一致预期本季度Amneal Pharmaceuticals, Inc.营收为8.08亿美元，同比增14.18%；调整后每股收益为0.19美元，同比增21.05%；息税前利润为1.47亿美元，同比增5.37%；公司在上一季度的公开信息中未披露对本季度毛利率、净利率或净利润的具体指引。从已披露的机构观点来看，市场呈现偏多态势：2026年01月07日，Truist Securities将Amneal Pharmaceuticals, Inc.目标价由14.00美元上调至15.00美元并维持买入评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Amneal Pharmaceuticals, Inc.本季度营收预计增14.18%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRX"],"gpt_icon":0},{"id":"1122001863","title":"Amneal Pharma：贷款人同意将19.6亿美元现有定期贷款转为新定期贷款","url":"https://stock-news.laohu8.com/highlight/detail?id=1122001863","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122001863?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:17","pubTimestamp":1770117452,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新备案文件显示，Amneal Pharmaceuticals, Inc.已获得贷款人同意，将现有定期贷款转换为金额达19.6亿美元的新定期贷款。这一重大财务重组举措将优化公司债务结构，为未来业务发展提供更灵活的资本支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMRX"],"gpt_icon":0},{"id":"1179923259","title":"Amneal获得美国FDA批准，单剂和多剂装肾上腺素注射剂可用于美国医院","url":"https://stock-news.laohu8.com/highlight/detail?id=1179923259","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179923259?lang=zh_cn&edition=full","pubTime":"2025-12-10 05:02","pubTimestamp":1765314150,"startTime":"0","endTime":"0","summary":"Amneal获得美国FDA批准，单剂和多剂装肾上腺素注射剂可用于美国医院","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRX","BK4007"],"gpt_icon":0},{"id":"1182720334","title":"Amneal公布Crexont®针对帕金森病的积极中期四期Elevate-Pd研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1182720334","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182720334?lang=zh_cn&edition=full","pubTime":"2025-12-05 21:03","pubTimestamp":1764939799,"startTime":"0","endTime":"0","summary":"Amneal公布Crexont®针对帕金森病的积极中期四期Elevate-Pd研究结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRX","BK4007"],"gpt_icon":0},{"id":"1172047286","title":"异动解读 | 分析师上调目标价，安耐尔制药盘中大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1172047286","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172047286?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:42","pubTimestamp":1761918173,"startTime":"0","endTime":"0","summary":"周五盘中，安耐尔制药股价大幅上涨5.10%，引发市场关注。此轮涨势主要受多家华尔街分析师上调公司目标股价的利好消息推动。根据最新报道，投资银行Piper Sandler将安耐尔制药的目标价从11美元上调至13美元，上调幅度达18%。值得注意的是，这些目标价的上调或反映出分析师对安耐尔制药未来业务发展和财务表现的乐观预期。目前，市场将密切关注安耐尔制药接下来的业绩表现，以验证分析师的预期是否准确。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMRX"],"gpt_icon":0},{"id":"1104203547","title":"异动解读 | 分析师上调目标价，Amneal制药股价盘中大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104203547","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104203547?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:42","pubTimestamp":1761918157,"startTime":"0","endTime":"0","summary":"周五（10月31日）盘中，Amneal制药（AMRX）股价大涨5.10%，引发市场关注。\n\n推动股价上涨的主要因素是分析师的积极评级。Piper Sandler将Amneal制药的目标价从11美元上调至13美元，显示出对该公司未来发展前景的信心。此外，Truist Securities也将该公司的目标价从13美元上调至14美元，进一步提振了投资者信心。\n\n分析师的看好反映出Amneal制药在业务发展和市场竞争力方面可能取得了一定进展。然而，具体的业绩表现和增长动力还需要进一步观察。投资者应密切关注公司未来的财务报告和业务发展情况，以评估其长期投资价值。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMRX"],"gpt_icon":0},{"id":"1175694764","title":"Kashiv Biosciences宣布向美国FDA提交生物制品许可申请，欧洲药品管理局接受其Adl-018市场授权申请，该产品为Xolair®（奥马珠单抗）拟议生物类似药","url":"https://stock-news.laohu8.com/highlight/detail?id=1175694764","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175694764?lang=zh_cn&edition=full","pubTime":"2025-10-06 20:02","pubTimestamp":1759752138,"startTime":"0","endTime":"0","summary":"Kashiv Biosciences近日宣布，已向美国食品药品监督管理局（FDA）提交生物制品许可申请，同时欧洲药品管理局已接受其市场授权申请。此次申请涉及的产品为Adl-018，这是一款拟议的Xolair®（奥马珠单抗）生物类似药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRX","BK4007","BK4139","ALVO"],"gpt_icon":0},{"id":"1119683393","title":"异动解读 | AMRX盘中大跌8.65% 利润增长放缓引发对未来获利能力担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1119683393","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119683393?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:59","pubTimestamp":1740754782,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals今日盘中股价大跌8.65%,引发市场广泛关注。公司近期公布的2024年第四季度财报显示,尽管销售额同比大涨18.4%至7.3052亿美元,高于市场预期,但每股收益仅为0.12美元,同比下滑14.3%,低于预期的0.15美元。利润增长乏力引发了投资者对公司未来获利能力的担忧。但投资者似乎暂时仍没有从最新财报中获得足够信心,导致AMRX股价今日承压大跌。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMRX"],"gpt_icon":0},{"id":"2514934715","title":"Amneal Pharmaceuticals(AMRX.US)：2024年Q4财报实现营收7.305亿美元，前值为6.17亿美元，预期值为7.081亿美元；每股收益为0.12美元，前值为0.14美元，预期值为0.15美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514934715","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514934715?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:11","pubTimestamp":1740741099,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals(AMRX.US)：2024年Q4财报实现营收7.305亿美元，前值为6.17亿美元，预期值为7.081亿美元；每股收益为0.12美元，前值为0.14美元，预期值为0.15美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28191148462273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AMRX"],"gpt_icon":0},{"id":"1109132024","title":"Amneal制药公司2024年第四季度调整后每股收益$0.12，低于预期$0.15，销售额$7.3052亿，超出预期$7.0755亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1109132024","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109132024?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:09","pubTimestamp":1740740982,"startTime":"0","endTime":"0","summary":"Amneal制药公司报告季度每股收益为$0.12，比分析师一致预期的$0.15低20%。这比去年同期每股收益的$0.14减少了14.29%。公司报告季度销售额为$7.3052亿，比分析师一致预期的$7.0755亿高3.25%。以上内容来自Benzinga Earnings专栏，原文如下：Amneal Pharmaceuticals  reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.15 by 20 percent. This is a 14.29 percent decrease over earnings of $0.14 per share from the same period last year.  The company reported quarterly sales of $730.52 million which beat the analyst consensus estimate of $707.55 million b","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amneal制药公司2024年第四季度调整后每股收益$0.12，低于预期$0.15，销售额$7.3052亿，超出预期$7.0755亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRX"],"gpt_icon":0},{"id":"2505435070","title":"Amneal Pharmaceuticals, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505435070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505435070?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:14","pubTimestamp":1737648855,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时14分，Amneal Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.16%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.19%。其相关个股中，Eton Pharmaceuticals, Inc.、阿玛琳、大自然药业涨幅较大，Inmed Pharmaceuticals Inc.、Incannex Healthcare Inc.、Painreform Ltd.较为活跃，换手率分别为18.91%、7.61%、6.74%，振幅较大的相关个股有Gelteq Limited、Inmed Pharmaceuticals Inc.、Im Cannabis Corp.，振幅分别为12.89%、12.50%、10.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001415a22d1f36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001415a22d1f36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMRX","BK4007"],"gpt_icon":0},{"id":"2503775996","title":"Amneal Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503775996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503775996?lang=zh_cn&edition=full","pubTime":"2025-01-16 05:00","pubTimestamp":1736974823,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日05时00分，Amneal Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.03%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.61%。Amneal Pharmaceuticals, Inc.公司简介：Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It also engages in the development, manufacture and sale of branded products. The company was founded in 2017 and is headquartered in Bridgewater, NJ.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011605002398678c1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011605002398678c1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMRX"],"gpt_icon":0},{"id":"2492227155","title":"Amneal Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492227155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492227155?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:03","pubTimestamp":1734552223,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时03分，Amneal Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.02%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为1.31%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Procaps Group S.A. C/Wts 29/09/2026 、坎伯兰药业涨幅较大，Petros Pharmaceuticals, Inc.、Quantum Biopharma Ltd.、Painreform Ltd.较为活跃，换手率分别为68.14%、28.00%、18.45%，振幅较大的相关个股有Quantum Biopharma Ltd.、Im Cannabis Corp.、Bioage Labs, Inc.，振幅分别为53.90%、37.44%、27.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040343ab828f92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040343ab828f92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMRX"],"gpt_icon":0},{"id":"2492993726","title":"Amneal Pharmaceuticals, Inc.盘中异动 快速上涨5.03%报8.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492993726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492993726?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:40","pubTimestamp":1734457237,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时40分，Amneal Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.03%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.50%。其相关个股中，Petros Pharmaceuticals, Inc.、梯瓦制药、Procaps Group S.A. C/Wts 29/09/2026 涨幅较大，Petros Pharmaceuticals, Inc.、Cbdmd, Inc.、Painreform Ltd.较为活跃，换手率分别为130.66%、19.86%、12.46%，振幅较大的相关个股有Petros Pharmaceuticals, Inc.、Scilex Holding Company C/Wts 10/11/2027 、Medicus Pharma Ltd.，振幅分别为38.13%、25.00%、24.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218014037a1f65d9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218014037a1f65d9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMRX","BK4007"],"gpt_icon":0},{"id":"2488073106","title":"Amneal Pharmaceuticals, Inc.盘中异动 急速拉升5.02%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488073106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488073106?lang=zh_cn&edition=full","pubTime":"2024-12-03 03:02","pubTimestamp":1733166169,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日03时02分，Amneal Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.02%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.46%。Amneal Pharmaceuticals, Inc.公司简介：Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It also engages in the development, manufacture and sale of branded products. The company was founded in 2017 and is headquartered in Bridgewater, NJ.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203030249a267159b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203030249a267159b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMRX"],"gpt_icon":0},{"id":"2483709093","title":"Amneal Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.00%报8.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483709093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483709093?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:55","pubTimestamp":1731682555,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时55分，Amneal Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.00%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为1.92%。Amneal Pharmaceuticals, Inc.公司简介：Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It also engages in the development, manufacture and sale of branded products. The company was founded in 2017 and is headquartered in Bridgewater, NJ.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115225555abc4f3f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115225555abc4f3f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMRX"],"gpt_icon":0},{"id":"1179076959","title":"异动解读 | Amneal Pharmaceuticals股价大涨5%引发市场关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1179076959","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179076959?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:22","pubTimestamp":1731338552,"startTime":"0","endTime":"0","summary":"当日上午,制药公司Amneal Pharmaceuticals股价出现大涨行情,截至发稿时已上涨5.15%,报收9.17美元/股。这一涨幅引发了市场广泛关注。分析人士认为,这可能与该公司的基本面表现不错相关。公司最新财报显示,Amneal Pharmaceuticals营收达7.02亿美元,毛利率较高,达到38.5%。尽管净利润出现小幅亏损,但上市公司整体业绩表现优异。与此同时,当日整个制药行业股票普遍上涨,行业景气度较高也可能推动Amneal Pharmaceuticals股价走强。行业相关个股中,Sonoma Pharmaceuticals、Assertio Holdings等公司股价表现也相当出色。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMRX"],"gpt_icon":0},{"id":"2482736646","title":"Amneal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482736646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482736646?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:15","pubTimestamp":1731338157,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时15分，Amneal Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.04%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.02%。其相关个股中，Evotec Se、Sonoma Pharmaceuticals, Inc.、Assertio Holdings, Inc.涨幅较大，Sonoma Pharmaceuticals, Inc.、Mira Pharmaceuticals, Inc.、Rockwell Medical, Inc.较为活跃，换手率分别为30.47%、2.02%、1.99%，振幅较大的相关个股有Sonoma Pharmaceuticals, Inc.、Rockwell Medical, Inc.、Mira Pharmaceuticals, Inc.，振幅分别为19.64%、11.74%、11.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111231557971a5be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111231557971a5be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMRX","BK4007"],"gpt_icon":0},{"id":"2481101544","title":"Amneal Pharmaceuticals, Inc.盘中异动 股价大跌8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101544?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:31","pubTimestamp":1731076307,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时31分，Amneal Pharmaceuticals, Inc.股票出现异动，股价快速跳水8.25%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.28%。其相关个股中，Alpha Teknova, Inc.、德纳维制药、基立福涨幅较大，Evoke Pharma, Inc.、Akanda Corp.、Biofrontera Inc.较为活跃，换手率分别为1.53%、1.14%、0.70%，振幅较大的相关个股有Flora Growth Corp.、Amneal Pharmaceuticals, Inc.、Cardiol Therapeutics Inc.，振幅分别为7.39%、7.32%、5.80%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822314795bdeee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822314795bdeee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMRX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amneal.com;investors.amneal.com","stockEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":-0.1779},{"period":"3month","weight":-0.0717},{"period":"6month","weight":0.2276},{"period":"1year","weight":0.3764},{"period":"ytd","weight":-0.054}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amneal Pharmaceuticals, Inc.是特拉华州的一家公司。该公司是一家多元化的全球性生物制药企业，开发、制造、营销和分销广泛的药品组合。它通过三个部门运营：普药部门，包括零售仿制药和注射剂；特药部门，专注于中枢神经系统和内分泌疾病的品牌药；以及AvKARE部门，为美国政府及零售市场提供分销服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008492},{"month":2,"riseRate":0.75,"avgChangeRate":0.016211},{"month":3,"riseRate":0.375,"avgChangeRate":-0.034673},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.000477},{"month":5,"riseRate":0.571429,"avgChangeRate":0.023897},{"month":6,"riseRate":0.25,"avgChangeRate":-0.009894},{"month":7,"riseRate":0.5,"avgChangeRate":-0.022797},{"month":8,"riseRate":0.625,"avgChangeRate":0.036251},{"month":9,"riseRate":0.375,"avgChangeRate":-0.005103},{"month":10,"riseRate":0.75,"avgChangeRate":0.012362},{"month":11,"riseRate":0.5,"avgChangeRate":0.037801},{"month":12,"riseRate":0.625,"avgChangeRate":0.062319}],"exchange":"NASDAQ","name":"Amneal Pharmaceuticals, Inc.","nameEN":"Amneal Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amneal Pharmaceuticals, Inc.(AMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amneal Pharmaceuticals, Inc.(AMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amneal Pharmaceuticals, Inc.,AMRX,Amneal Pharmaceuticals, Inc.股票,Amneal Pharmaceuticals, Inc.股票老虎,Amneal Pharmaceuticals, Inc.股票老虎国际,Amneal Pharmaceuticals, Inc.行情,Amneal Pharmaceuticals, Inc.股票行情,Amneal Pharmaceuticals, Inc.股价,Amneal Pharmaceuticals, Inc.股市,Amneal Pharmaceuticals, Inc.股票价格,Amneal Pharmaceuticals, Inc.股票交易,Amneal Pharmaceuticals, Inc.股票购买,Amneal Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amneal Pharmaceuticals, Inc.(AMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amneal Pharmaceuticals, Inc.(AMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}